Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gordon

Showing results (611-620 of 629) with videos related to

Pageof 63
Sort By:
Journal of Virology|January 4, 2020
Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in MacaquesIsabela Silva de Castro, Shari N Gordon, Jun Liu, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Clinical Immunology (Orlando, Fla.)|September 18, 2014
Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaquesAntonio Valentin, Katherine McKinnon, Jinyao Li, et al.
NPJ Vaccines|April 10, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2016
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 AcquisitionShari N Gordon, Namal P M Liyanage, Melvin N Doster, et al.
NPJ Vaccines|November 7, 2021
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2014
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responsesDiego A Vargas-Inchaustegui, Iskra Tuero, Venkatramanan Mohanram, et al.
Science Advances|August 22, 2020
Development of a potent Zika virus vaccine using self-amplifying messenger RNAKate Luisi, Kaitlyn M Morabito, Katherine E Burgomaster, et al.
Science Translational Medicine|June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody qualitySonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Plos Pathogens|March 13, 2020
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisitionGiacomo Gorini, Slim Fourati, Monica Vaccari, et al.
Pageof 63

Showing results (611-620 of 629) with videos related to

Sort By:
Pageof 63
Journal of Virology|January 4, 2020
Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in MacaquesIsabela Silva de Castro, Shari N Gordon, Jun Liu, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Clinical Immunology (Orlando, Fla.)|September 18, 2014
Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaquesAntonio Valentin, Katherine McKinnon, Jinyao Li, et al.
NPJ Vaccines|April 10, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 4, 2016
Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 AcquisitionShari N Gordon, Namal P M Liyanage, Melvin N Doster, et al.
NPJ Vaccines|November 7, 2021
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.
Clinical Immunology (Orlando, Fla.)|June 8, 2014
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responsesDiego A Vargas-Inchaustegui, Iskra Tuero, Venkatramanan Mohanram, et al.
Science Advances|August 22, 2020
Development of a potent Zika virus vaccine using self-amplifying messenger RNAKate Luisi, Kaitlyn M Morabito, Katherine E Burgomaster, et al.
Science Translational Medicine|June 12, 2020
Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody qualitySonia Maciejewski, Tracy J Ruckwardt, Kaitlyn M Morabito, et al.
Plos Pathogens|March 13, 2020
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisitionGiacomo Gorini, Slim Fourati, Monica Vaccari, et al.
Pageof 63